VEGFA and breast cancer: Additionally, women with a history of preeclampsia, who during their pregnancy experience pronounced elevations in the anti-angiogenic factor sFlt-1 (also known as soluble VEGF receptor 1) along with low circulating VEGF and PlGF, have a reduced risk of subsequent breast cancer [13–16].